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Depression of the cellular immune response to Toxoplasma gondii has been reported in both mice and
humans. The present study was undertaken to determine the kinetics and mechanism of the observed
downregulation of interleukin 2 (IL-2) production during experimental murine toxoplasmosis. For these
investigations, the cell-mediated immune response to the wild type (PTg) was compared with that to the
less-virulent mutant parasite (PTgB), which is deficient in the major surface antigen, p30 (SAG-1). Spleen cells
from infected AJJ mice failed to proliferate in response to Toxoplasma antigens during the first week of
infection. Both PTg- and PTgB-infected A/J mice exhibited a significant reduction in the concanavalin A (Con
A)-induced lymphoproliferative response. Further, the response of splenocytes from mice infected with the
wild-type parasite was significantly diminished compared with that of mice infected with PTgB. The
lymphoproliferative response to Con A reached its nadir at day 7 and remained below control levels for at least
14 days postinfection. By day 21 postinfection, the response to Con A and to Toxoplasma antigens was restored
to the level observed prior to day 7. Con A-stimulated culture supernatants of spleen cells from mice on day
7 postinfection contained significantly less IL-2 than pormal mice. There was no significant difference in the
numbers of binding sites or capacity of high-affinity IL-2 receptors between infected and normal mouse
splenocytes as determined by Scatchard analysis. Exogenous IL-2 at different concentrations failed to restore
the proliferative response of lymphocytes from infected mice to Con A. Adherent macrophages from
7-day-infected mice were able to suppress IL-2 production by normal splenocytes following stimulation with
Con A. The inhibitory activity mediated by infected cells was reversed by the antibody to IL-10 but not
transforming growth factor [B. There were insignificant levels of nitric oxide production in both infected and
normal splenocytes. These results indicate that during acute murine toxoplasmosis, there is a well-defined
period (day 7) during which both the T-cell mitogen and parasite antigen-associated lymphoproliferative
response are reduced. Further, there is a reduction in the production of IL-2 and an increase in IL-10, which
appear to mediate, in part, the observed downregulation of immunity to T. gondii.
Toxoplasmic encephalitis caused by the obligate intracellu-
lar protozoan Toxoplasma gondii is the most common central
nervous system infection in those afflicted with AIDS. It is
primarily manifested when the CD4+ T-cell population is
depleted and in the setting of a falling CD8+ T-cell count (27).
Recent studies of mice with the murine LP-BM5 virus
(MAIDS) have demonstrated increased mortality in those
mice coinfected with T. gondii, suggesting that the parasite is
able to induce a state of immunodepression in an already
compromised host (15). Earlier studies of mice have demon-
strated that cell-mediated immunity is depressed following
parasite infection in the normal host (8, 23, 38). Similar
observations have been made in humans (4, 26). The depres-
sion of lymphocyte proliferative responsiveness to the Toxo-
plasma antigen was observed in an infant with congenital
toxoplasmosis (28) and in adults with acute toxoplasmosis (26).
Downregulation of T-cell-derived cytokines, in particular
interleukin 2 (IL-2), during infection with other protozoan
parasites, intracellular bacteria, or viruses has been demon-
strated. For example, concanavalin A (Con A)-stimulated
T-cell culture supernatant collected at 7 days postinfection
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with lymphocytic choriomeningitis virus contained a 30- to
40-fold-reduced amount of IL-2 (34). Similar observations
have been reported during Trypanosoma cruzi infection in mice
(7, 11).
The potential role of activated macrophages in downregu-
latory host immune response is well recognized. Activated
macrophages are known to secrete a variety of factors with
suppressive activities, including IL-10 (12, 14), transforming
growth factor ,B (TGF-13) (42), nitric oxide (2, 30), and
prostaglandin (32). Murine IL-10 has a variety of immune
downregulatory properties, including decreased IL-2 produc-
tion (14, 40) and the inhibition of T-cell proliferation by Con A
in the presence of accessoxy cells (12).
Our laboratory has been interested in studying the host
response to p30 (SAG-1), a major surface protein of T. gondii.
This antigen has an apparent Mfr of 30,000 and is important in
controlling host immunity to the parasite (21). We have used
monoclonal antibodies (MAb) directed at this protein to
isolate a mutant parasite deficient in p30, PTgB (18, 22). In the
current study, we use this antigen-deficient mutant to investi-
gate the host immune response. Our results indicate that T.
gondii is able to induce a transient state of reduced lymphocyte
proliferation in mice infected with either wild-type or p30
antigen-deficient parasites. To better appreciate the mecha-
nism underlying the impaired cellular immune response,
splenocytes from T. gondii-infected mice were examined for
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the production of IL-2 and binding of the IL-2 receptor to its
ligand (i.e., IL-2). We report that spleen cells from infected
mice were defective in their capacity to both secrete IL-2 and
respond to exogenous IL-2. In addition, we observed the
suppressive effect of macrophages from mice acutely infected
with T. gondii on the production of IL-2. The culture superna-
tant obtained from these macrophages tontained increased
levels of IL-10. Antibody to IL-10 can partially restore the
suppressed Con A-proliferative response by this supernatant.
MATERLILS AND METHODS
Parasite and antigen preparation. The P strainof T. gondii
(PTg) and its derived mutant PTgB were used for all experi-
ments. The P strain used in these experiments was cloned from
the Me49 strain (20). The p30-deficient mutant strain, PTgB,
was selected from a large population of chemically mu-
tagenized wild-type P strain parasites (18) as previously re-
ported. All parasites in these experiments were used between
the 1st and 35th passage in vitro. Parasites were maintained in
our laboratory by in vitro passage in human foreskin fibroblasts
at 37°C in minimal essential medium (MEM) containing 10%
newborn calf serum. To prepare Toxoplasma antigen (TGA),
infected human foreskin fibroblast monolayers were scraped,
and the tachyzoites were freed by forced extrusion through a
27-gauge needle. The lysate was centrifuged at 590 x g for 10
min, and the pellet was resuspended in serum-free medium.
Tachyzoites were separated from host-cell debris by treatment
with phytohemagglutinin-M, as previously reported, followed
bypassage through a glass-wool filter (19). The parasites were
then washed twice in serum-free medium and centrifuged at
590 x g for 10 min, and the pellet was lysed by repeated
freezing at -70°C and thawing at 37°C. This material was then
centrifuged at 590 x g for 10 min, and the supernatant was
collected and sterilized by passage through a polysulfone
membrane filter with a 0.22-,um-pore diameter (Gelman, Ann
Arbor, Mich.). The protein concentration was determined
by the Bradford method (Bio-Rad Laboratories, Richmond,
Calif.) with bovine serum albumin as a standard.
Mice and infection. Female A/J mice, 5 to 6 weeks old, were
obtained from Jackson Laboratories, Bar Harbor, Maine).
Mice were infected intraperitoneally with 2 x 104 parasites,
and the proliferative response of splenocytes, in the presence
of soluble TGA and mitogen, Con A (Sigma Chemical Co., St.
Louis, Mo.), were analyzed at different times after infection.
Experiments were extended up to 21 days postinfection with
surviving PTgB- or PTg-infected mice. Each experimental
group consisted of at least 12 mice.
Lymphocyte preparation and cell culture. Following para-
site infection, mice from each group were sacrificed, and cell
suspensions were prepared from spleens or lymph nodes
following homogenization of these tissues in phosphate-buff-
ered saline (PBS). Erythrocytes were lysed by hypotonic shock
with 0.2% ammonium chloride. The cells were then washed
with PBS, followed by Iscove's medium containing 2 mM
L-glutamine, 10 mM HEPES (N-hydroxyethylpiperazine-N'-2-
ethanesulfonic acid), and 10% fetal bovine serum (FBS; Hy-
clone Laboratories, Logan, Utah). For proliferative assays, the
cells were cultured in triplicate wells at a concentration of 2 X
105 cells per well in 96-well flat-bottom culture plates in a final
volume of 200 RI of Iscove's medium-10% FBS containing
TGA, Con A, or neither. In preliminary experiments, the
lymphoproliferation in response to TGA (8.75 pug/ml) and Con
A was determined (data not shown). Cells were cultured for
either 4 days with TGA or 2 days with Con A (5 p,g/ml) in a
humidified chamber at 37°C containing 5% CO2. Culture
supernatants were obtained at 24 h after culture. Forprolifer-
ation assays, cell cultures were pulsed with 0.5,uCiof[3H]thy-
midine (ICN, Costa Mesa, Calif.) for 6 h at 37°C. Pulsed cells
were harvested on glass filter strips with an automated multiple
sample cell harvester and dried, and the radioactivity was
determined by liquid scintillation.
Adherent and nonadherent cell preparations. Spleen cells
were isolated from each group of mice, and cell suspensions
were prepared as described above. Nonadherent cells were
prepared by incubating either normal uninfected spleen cells
(5 x 106/ml) or spleen cells (5 x 106/ml) from mice at day 7
postinfection in a 100-mm-diameter plastic petri dish (Corning
Glass Works, Corning, N.Y.) at 37°C in a humidified atmo-
sphere containing 5% CO2. After 2 h of incubation, medium
containing nonadherent cells was collected, and the cells were
washed, separated by centrifugation (590 x g for 10 min), and
resuspended at a concentration of 4 x 106/ml of Iscove's
medium containing 10% FBS. The nonadherent cells were
about 80% Thy 1.2 positive by fluorescence-activated cell
sorter (Ortho Diagnostics) (FACS) analysis. For proliferation
assays, the cells were cultured in triplicate wells at a concen-
tration of 2 x 105 cells per well in a final volume of 200 [lI of
Iscove's medium-10% FBS with or without Con A.
The adherent cells were gently washed twice with culture
medium containing 10% FBS. Cells were dissociated by the
addition of 5 ml of 0.02% EDTA (Sigma Chemical Co.) for 5
min at 37°C. The cells were further dissociated by repeatedly
pipetting EDTA solution over the entire surface of each petri
dish. Once dissociated, the cells were washed twice with
medium. The adherent cell population contained about 95%
macrophages as determined by Wright-stained morphology.
The number of macrophages was determined microscopically
by counting five fields. For proliferation assays, different
concentrations of dissociated adherent cells (105 or 3 x 105
cells per well) were cultured with spleen cells from age-
matched normal uninfected mice (2 x 105 cells per well) in
triplicate wells of 96-well culture plates in a final volume of 200
RI of Iscove's medium-10% FBS with or without Con A.
Culture supernatants were obtained at 24 h after culture, and
the IL-2 activity of these supernatants was tested by their
ability to stimulate proliferation of an IL-2-dependent murine
T-cell clone (16). All cultures were incubated at 37°C in a 5%
CO2 atmosphere for 48 h. [3H]thymidine (0.5 ,uCi; ICN) was
added to each well for the final 6 h of culture. Incorporated
radioactivity was determined by liquid scintillation counting.
Data were expressed as counts per minute.
Flow microfluorometry. Flow cytometric analysis of spleno-
cytes was performed by single color, indirect fluorescence with
the use of an FACS. Briefly, 106 spleen cells in suspension from
uninfected or infected mice were incubated for 1 h at 4°C with
either anti-CD4+ GK 1.5 (TIB 207; American Type Culture
Collection, Rockville, Md.), anti-CD8 (TIB 150; American
Type Culture Collection) or anti-Thy 1.2 (CHO-13.4; Ameri-
can Type Culture Collection) MAb. Analysis of the yB-het-
erodimer was accomplished with MAb (3A10) directed at this
receptor (kindly supplied by Susumi Tonegawa, Center for
Cancer Research, Massachusetts Institute of Technology,
Cambridge). Cells were washed with PBS and incubated with
fluoroscein-conjugated anti-rat, anti-mouse, and anti-hamster
immunoglobulin G. After 45 min, the cells were washed twice
with PBS, fixed with 0.1% methanol-free formaldehyde, and
then analyzed by flow cytometry.
Assay of IL-2 and IL-10 production. Supernatants from
cultures of Con A-stimulated splenocytes from normal unin-
fected or infected mice were collected at 24 h after the
beginning of culture. IL-2 activity in the supernatants was
VOL. 62, 1994
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tested by their ability to stimulate proliferation of an IL-2-
dependent murine T-cell clone (16). CTLL-2 cells (3.5 x 103
cells per well) were suspended in culture medium containing
10% FBS. CTLL proliferation, as indicated by incorporation of
0.5 ,uCi of [3H]thymidine, was determined during the last 6 h of
the 24-h culture period in the presence of serial twofold
dilutions of standard recombinant (rIL-2) and experimental
samples. Radioactive incorporation was determined by liquid
scintillation spectroscopy. The response was analyzed by Probit
analysis as described previously (16) compared with the 50%
maximal response obtained with standard rIL-2 (kindly pro-
vided by Kendall A. Smith, Dartmouth Medical School,
Hanover, N.H.). For IL-10 measurement, supernatants from
48-h splenocyte culture stimulated with Con A were assayed by
enzyme-linked immunosorbent assay (ELISA) per the manu-
facturer's instruction (Endogen, Boston, Mass.), and the cyto-
kine level was calculated by reference to standard units pro-
vided by the manufacturer.
Receptor-binding assay. A radioisotope assay was used to
evaluate IL-2 receptor binding as previously described (43).
Briefly, splenocytes from uninfected or infected (for 7 days)
mice were cultured in the presence of 5 jig of Con A per ml for
48 h. The cells were washed in Iscove's medium containing 2
mM L-glutamine, 10 mM HEPES (pH 7.2), and 10% FBS.
Serial dilutions of 125I-IL-2 (provided by Kendall A. Smith)
were incubated at 37°C with 4 x 105 to 6 x 105 spleen cells in
a total volume of 200 ,u of culture medium for 20 min. After
incubation, the bound and free 125I-IL-2 were separated by
centrifugation at 8,500 g for 2 min through 20% paraffin oil
(Fisher Scientific Co., Pittsburgh, Pa.) and 80% silicon oil (550
fluid; Contour Chemical Co., North Reading, Mass.). The tips
of the tubes (400 ,ul, polyethylene; USA Scientific Plastics,
Ocala, Fla.) containing the cell pellet and free radioactivity
were cut off, and the radioactivity was determined by scintilla-
tion counting. The number of binding site and the dissociation
constant (Kd) values were determined by Scatchard analysis as
previously described (43). The number of binding sites per cell
and the calculated dissociation constant values are based on
the specific activity of 5 x 105 molecules per cpm.
Assays with anti-IL-10 and anti-TGF-4 MAbs. MAb to
IL-10 and TGF-P were used to investigate the effect of these
cytokines on the proliferative cell response. Rat anti-mouse
IL-10 antibody (Genzyme, Cambridge, Mass.) or anti-TGF-,
antibody (mouse anti-TGF-,1, TGF-P2, or TGF-43 MAb;
Genzyme) was used at concentrations as recommended by the
manufacturer. Splenocytes were prepared from either unin-
fected or infected (for 7 days) A/J mice as described above.
Cells were cultured in triplicate wells at a concentration of 2 x
105 cells per well with either anti-IL-10 (4 ,ug/ml), anti-TGF-,
(30 ,ug/ml) or normal rat immunoglobulin G (Sigma Chemical
Co.). Cells were incubated either with anti-IL-10 or anti-
TGF-,B for 30 min at 37°C followed by the addition of either
Con A or medium. After 48 h of incubation, the proliferation
was determined by the amount of [3H]thymidine incorporated.
Data were expressed as counts per minute.
Nitrite determination. Nitrite in 24-h culture supernatants
was measured by using Griess reagent (13). Briefly, 0.05 ml of
supernatant was mixed with 0.05 ml of Griess reagent and then
incubated for 10 min at room temperature, and A570 was
determined with an automated plate reader. The nitrite con-
centration was calculated from a NaNO2 (Sigma Chemical
Co.) standard curve.
Statistical analysis. Probability significance was determined
by two-tailed Student's t test, assuming equal variances. Statis-
tical significance was set at P of <0.05 for all comparisons.
RESULTS
Splenocyte proliferative response to Con A. We first evalu-
ated the in vitro lymphoproliferative response to Con A in A/J
mice infected with either P wild-type or PTgB mutant para-
sites. Splenocytes were harvested at various times after infec-
tion and cultured for 48 h in the presence of Con A. Following
incubation, lymphoproliferation was determined by the
amount of [3H]thymidine incorporated. As shown in Fig. 1,
there was a gradual decline in the proliferative response to
Con A during the first week of infection. This reduction in
proliferation reached its nadir on day 7 postinfection in both
PTg- and PTgB (P < 0.05)-infected mice compared with that in
normal age-matched uninfected control mice. In addition, the
Con A-induced response on day 7 was significantly lower in
splenocytes obtained from PTg-infected mice than from PtgB-
infected mice (P < 0.05). By day 14, this difference is no longer
significant, although the Con A response in splenocytes from
mice infected by either strain remained significantly lower than
that in uninfected controls (P < 0.05). By day 21 postinfection,
the difference in Con A-induced stimulation between infected
and uninfected mice virtually disappeared.
Proliferative response to TGA. The ability of TGA to
stimulate splenocytes from infected mice was then evaluated.
As shown in Fig. 2A, at a concentration of 8.75 ,ug TGA per
ml, splenocytes obtained from wild-type infected mice failed to
proliferate in response to parasite antigen during the first week
of infection. By days 14 and 21, however, the ability to
proliferate in response to parasite antigen was significant (P <
0.05). Similar observation were made for splenocytes from the
PTgB-infected mice (Fig. 2B).
Phenotypic analysis of mouse T-cell subpopulations.
Splenocytes were isolated from infected mice at days 3, 7, and
14 postinfection, and the expression of T-cell phenotypes was
analyzed by FACS. As shown in Table 1, there was a significant
increase in the number of CD8+ T cells in both wild-type- and
PTgB-infected mice on days 7 and 14 postinfection. CD8+
T-cell augmentation was most pronounced in wild-type-in-
fected mice at day 14 following infection. Infection with either
PTg or PTgB parasites induced a low level of yB T-cell
response (5%) in the A/J mice. By day 14 postinfection, 8.6%
of the splenocyte population analyzed was positive for ryb-
heterodimers.
Adherent cells suppress the Con A response of lymphocytes
from uninfected or infected mice. Con A-stimulated prolifer-
ative responses of spleen cells from uninfected mice were
studied in the presence of different concentrations of adherent
cells (105 and 3 x 105 cells per well) obtained at day 7
postinfection from spleens of either wild-type- or PTgB-
infected mice. Day 7 was chosen since the results indicated this
was the time at which the proliferative response to Con A was
most affected. As shown in Fig. 3, there was a significant
decrease when normal spleen cells were incubated in the
presence of adherent cells from infected mice (P < 0.05). This
response was dependent on the number of adherent cells
added to the culture. Similar results were obtained when
spleen cells from mice infected with either the wild type or
PTgB were cocultured with adherent cells from mice infected
with either strain of T. gondii (data not shown).
IL-2 response during the course of primary infection.
Splenocytes were obtained from mice at days 3, 7, 14, and 21
postinfection and stimulated with either parasite antigen or
Con A. At 24 h, the culture supernatants were collected and
IL-2 production was measured in an IL-2-dependent CTLL
assay. In this bioassay, there was no detectable IL-2 produced
INFECr. IMMUN.
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FIG. 1. Proliferative response to Con A of splenocytes from mice infected with either T. gondii PTg or PTgB. The spleen cells were obtained
from uninfected mice or mice infected for 3, 7, 14, and 21 days and were cultured for 48 h in triplicate wells at a concentration of 2 x 105 cells
per well in presence of Con A (5 jLg/ml). Lymphoproliferation was determined on days 14 and 21 postinfection in only those PTg-infected mice
which had survived the infection. The proliferation was determined by the amount of [3H]thymidine incorporation, and the results are expressed
as means ± standard deviations (error bars) for triplicate wells. * and 1, normal uninfected mouse spleen cells without and with Con A,
respectively; U and O, PTg-infected spleen cells without and with Con A, respectively; El and 9, PTgB-infected spleen cells without and with Con
A, respectively. This experiment was repeated five times. For comparisons b versus a, c versus a, b versus c, e versus d, and f versus d, (P was <0.05).
For e versus f, P was >0.05.
by spleen cells from infected mice cultured for 24 h in the
presence or absence of parasite antigen (data not shown).
As shown in Table 2, the quantity of IL-2 produced by
infected mouse splenocytes after Con A stimulation was
significantly lower than that produced by uninfected spleno-
cytes. On all days evaluated, splenocytes from mice infected
with the wild-type strain produced less IL-2 in response to Con
A than splenocytes from mice infected with the mutant strain.
The type of splenocyte cells involved in the reduced (P > 0.05)
IL-2 production was evaluated. As shown in Table 3, coculture
in the presence of adherent cells from infected mice signifi-
cantly reduced the quantity of IL-2 detected in the superna-
tants of either uninfected or infected splenocytes.
Effect of exogenous IL-2 on splenocytes from infected mice.
The ability of exogenous IL-2 to overcome the depressed
proliferative response was evaluated for splenocytes from mice
on day 7 postinfection. The biological activity of rIL-2 was
confirmed by CTLL assay prior to use in this experiment. As
shown in Fig. 4, exogenous IL-2 at different concentrations
failed to reconstitute the depressed proliferative response to
Con A of the spleen cells from acutely infected mice.
Determination of binding sites and capacity of high-affinity
IL-2 receptors. To determine IL-2 receptor expression on
lymphocytes from infected mice, splenocytes on 7 day postin-
fection were isolated and cultured in the presence of Con A for
48 h. IL-2 receptor expression was measured in a binding assay
using radiolabeled rIL-2. A Scatchard analysis to determine
the number of binding sites per cell and the dissociation
constant (Kd) showed no significant differences between the
wild-type- and PTgB-infected splenocytes. There was, how-
ever, a threefold decrease in the number of binding sites per
cell in the infected mice (Table 4). Although splenocytes from
both infected and uninfected mice express high-affinity recep-
tors for IL-2, the difference in the Kd values between these
groups was insignificant (P > 0.05).
Role of IL-10, TGF-,I, and nitric oxide. To determine
whether IL-10 was responsible for the observed depressed
proliferative response to Con A, splenocytes obtained from
either 7-day-infected or uninfected mice were cultured, and
the supernatants were evaluated for the presence of IL-10.
As shown in Table 5, the splenocytes obtained from mice
infected with wild-type parasites produced considerable
amounts of IL-10 in comparison to uninfected control spleno-
cytes. Moreover, when the splenocytes from these infected
mice were cocultured with the adherent cells obtained from
7-day-infected mice, the amount of IL-10 expressed in the
supernatant was even greater. Antibody to IL-10 (at a con-
centration of 4 p,g/ml) partially reversed (approximately 60%)
the inhibitory response to Con A (Table 6). However, anti-
body to TGF-P failed to reverse the reduced proliferative
response.
The culture supernatants from 7-day-infected mice were
evaluated for the presence of nitric oxide. Splenocytes from
either 7-day-infected mice or uninfected controls were stimu-
lated with Con A, and the amount of NO produced was
determined by the Greiss reaction (13). The same number of
effector cells (2 x 105) that exhibited downregulatory activity
in previous experiments were used. In this assay, there was no
significant difference in the amount of NO produced by
infected splenocytes at 24 h (0.5 jiM) and 48 h (2.7 ,uM)
postculture. An equivalent amount of NO was produced when
the same number of normal spleen cells were stimulated with
Con A. Either increasing the number of cultured cells or
activating the macrophages with gamma interferon plus lipo-
polysaccharides enhanced the amount of detectable NO in the
culture supernatant. Other times postinfection were not eval-
uated since there was no detectable NO production during the
time of greatest reduction in the lymphoproliferative response
to Con A.
VOL. 62, 1994
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FIG. 2. Proliferative response to TGA of splenocytes from mice
infected with PTg (A) or PTgB (B) parasites or age-matched normal
uninfected mice. The splenocytes were cultured at a concentration of
2 x 105 per well in the presence of 8.75 ,ug of TGA per ml or of
unrelated antigen, tetanus toxoid (Tet Tox). The results are expressed
as means + standard deviations (error bars) for triplicates. This figure
shows the results of a set of four representative experiments. None,
cells with medium only; PTg Ag or PTgB Ag, cells were cultured in the
presence of PTg or PTgB antigen. Comparisons were made by using
the two-tailed Student t test. In panel A, B versus A, C versus A, E
versus D, and F versus D (P < 0.05); in panel B, b versus a, c versus
a, e versus d, and f versus d (P < 0.05).
DISCUSSION
Our data suggest that a well-delineated period of lympho-
cyte hyporesponsiveness occurs following primary T. gondii
infection in mice. During this period, there is an associated
reduction of IL-2 in response to Con A stimulation. Although
this reduced proliferative response and IL-2 production were
observed during the first 14 days postinfection, it was most
notable on day 7. These observations confirm previous reports
indicating that a state of immunodepression occurs during the
first 8 days of infection with T. gondii in both humans and
experimental models (8, 23, 38, 39). Our studies extend these
observations to at least 21 days, at which time the infected mice
regain their ability to respond to both parasite antigen or Con
A. Although both strains of parasite, the wild type and the
mutant, have the ability to induce a state of hypoproliferation,
the wild-type parasite had a greater influence on mediating this
response. Whether these differences are due to a lower para-
site burden or slower growth of the mutant remains unclear.
Current data from our laboratory indicate that mice infected
with the wild-type parasite die earlier and with greater fre-
quency than those infected with the mutant parasite.
A decrease in the quantity of IL-2 was observed in the
supernatant of cultured splenocytes from mice infected with
either parasite strain following Con A stimulation. This is
consistent with the finding of McLeod and coworkers, who also
reported a similar depression of IL-2 during the acute phase of
murine toxoplasmosis (29). We have observed an augmenta-
tion in CD8+ T cells that accompanies the period of dimin-
ished lymphocyte reactivity to parasite antigen or Con A. It is
possible that the depressed IL-2 response might be related to
the rise in CD8+ T cells, since CD8+ lymphocytes usually
produce high quantities of gamma interferon and little or no
IL-2 (31, 44). Analysis of the absolute T-cell count failed to
distinguish a significant difference in the number of T cells in
infected and uninfected mice. However, this does not exclude
a dissimilarity in the number of IL-2-producing cells between
these mice.
Our results demonstrated that the addition of exogenous
IL-2 had little effect on restoring the reduced proliferative
response of these splenocytes. Failure to revert this response
has previously been reported in viral (33), bacterial infection
(3), and other parasitic infection, in particular with T. cruzi
(17). In those studies, infection with either lymphocytic chori-
omeningitis virus or salmonellae resulted in reduced IL-2
production that could not be reversed by the addition of
exogenous IL-2. In contrast to our results, Chan et al. reported
restoration of suppressed proliferative response of spleen cells
from mice infected for 3 or 6 days with C56, an avirulent strain
of T. gondii (8). It is possible that differences in parasite strains
and the times tested may be responsible for this discrepency.
Also, in malaria infection, suppressed lymphoproliferative
responses are restored by exogenous IL-2 (10). The failure of
lymphocytes to proliferate in response to exogenous IL-2 led
us to examine the IL-2 binding property of the receptors on
lymphocytes from infected animals. The results from these
TABLE 1. Phenotypic analysis of mouse T-cell populations
% T-cell phenotypes (mean ± SD) with MAb:
Day Spenceltp
postinfection TpleenceThy 1.2 GK 1.5 TIB 150 3A10(CD4) (CD8) (y8 T cells) Negative
0 Uninfected 32 ± 1 24 ± 5 13 ± 3 0 ± 0 3 ± 1
3 PTg infected 31 ± 3 18 ± 3 14 ± 5 0.3 ± 0.2 5 ± 2
PTgB infected 32 ± 6 22 ± 4 15 ± 4 1 ± 0.6 7 ± 2
7 PTg infected 38 ± 4 23 ± 5 19 ± 4 5 ± 0 1 ± 0.5
PTgB infected 34 ± 2 24 ± 4 19 ± 2 6 ± 0 3 ± 2
14 PTg infected 37 ± 3 30 ± 2 25 ± 5 9 ± 0.9 2 ± 0
PTgB infected 24 ± 0 10 ± 0 19 ± 0 0 ± 0 2 ± 0.5
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Normal mouse splen cells
FIG. 3. Proliferative response to Con A of uninfected normal spleen cells cultured with adherent cell populations obtained from mice on day
7 postinfection or uninfected control mice. Adherent macrophages were isolated and cultured as described in Materials and Methods. Proliferation
was determined by the amount of [3H]thymidine incorporated, and the results are expressed as means ± standard deviations (error bars) of
triplicates. Data show a representative experiment with five mice per group. PTg M0, adherent cells from PTg-infected spleens; PTgB M0,
adherent cell from PTgB-infected spleens; NM M0, adherent cells from normal uninfected mouse spleens, NM only, uninfected spleen cells with
or without Con A. This experiment was repeated three times.
experiments showed a threefold decrease in the number of
IL-2 binding sites per cell in both PTg- and PTgB-infected
mice compared with cells from uninfected mice. However, the
binding affinity, as determined by the Kd values, remained the
same for cells from uninfected mice as well as from PTg- and
PTgB-infected mice. It is possible that among the nonrespond-
ing cell population, a defect in the IL-2 signaling pathway may
exist. Studies are currently underway to evaluate this possibil-
ity.
The results of our study demonstrated that macrophages
from infected mice reduce the lymphoproliferative response
when added to the culture by affecting IL-2 production of
normal uninfected splenocytes in response to Con A. This
macrophage-mediated downregulation of IL-2 production has
also been reported for bacterial infection (3). The inhibitory
activity was not limited to macrophages since the nonadherent
spleen cells from mice on day 7 postinfection also inhibited
T-cell proliferation and Con A-induced IL-2 production, al-
though to a lesser degree (data not shown).
The precise mechanism(s) of reduced IL-2 production dur-
TABLE 2. Production of IL-2 by Con A-stimulated spleen cellsa
Spleen cell IL-2 production (pM) on day postinfection indicated
type 3 7 14 21
Uninfected 60 7 94 ± 7 50 ± 4 80 8
PTg infected 55 4 <5 54 2 40 5
PTgB infected 90 ± 7 18 t 5 61 3 53 6
a Supernatants from 24 h cultures with Con A (5 ,ug/ml) of spleen cells
obtained from PTg- or PTgB-infected mice and age-matched control mice. The
supernatants were tested for the presence of IL-2 by the CITLL-2 cells prolifer-
ation assay as described in Materials and Methods. The data shown are the
results (± standard deviations) of one typical experiment of four experiments.
On day 7 postinfection, IL-2 production in splenocytes from PTg-infected mice
was significantly lower than that from PTgB-infected animals (P < 0.05) or from
uninfected mice (P < 0.05). For each time point, cultures in medium only had
levels of IL-2 that were below the detectable threshold (<2 pM).
ing primary T gondii infection remains unclear. The results of
our study demonstrate that macrophages from mice that are
acutely infected with T gondii can indeed inhibit Con A-stim-
ulated T-cell proliferation and can also affect production of
IL-2. The suppressive effect of macrophages on in vitro
lymphocyte proliferation in response to mitogens or parasite
antigens was previously suggested for malaria (24), trypanoso-
miasis (41), and toxoplasmal infections (8). Whole spleen cell
populations from either T gondii-infected mice (day 7) or
age-matched normal uninfected animals irradiated and added
to the culture of splenocytes from uninfected mice in the
presence of Con A resulted in decreased Con A-induced T-cell
proliferation, accompanied by reduced IL-2 production. The
mechanisms of suppressor function of macrophages are not
clearly understood. In addition to the production of soluble
factors with negative regulatory activity, a recent study also
suggested that macrophage-mediated downregulation of the
TABLE 3. Production of IL-2 by Con A-stimulated cocultured
spleen ceilsa
IL-2 production (pM) with:
Spleen cell Macrophages
type Con A lPrg- PTgB- Uifce
infected infected Uninfected
Uninfected 245 ± 59 21.8 ± 2 69 ± 7 240 ± 30
PTg infected 47 ± 6 19.5 ± 1.4 25 ± 4 43 ± 6
PTgB infected 60 ± 11 24 ± 5 22 ± 1.3 52 ± 8
a Uninfected spleen cells or spleen cells (2 x 105) from infected mice were
cocultured with adherent macrophages (3 x 105) from PTg- or PTgB-infected
(for 7 days) or uninfected spleens in the presence of Con A. Supernatants from
24-h cultures with Con A of cocultured cells were obtained, and the quantity of
IL-2 produced was determined by the CTLL-2 cell proliferation assay. The
proliferation was measured by [3H]thymidine incorporation. The response was
analyzed by Probate analysis as described previously (16) compared with the 50%
maximal response obtained with standard IL-2. The data shown are results (±
standard deviations) of one typical experiment of four experiments.
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FIG. 4. Effect of exogenous IL-2 on Con A-stimulated proliferative
response of splenocytes from PTg- or PTgB-infected mice. Different
concentrations of rIL-2 were added to the splenocytes of mice on day
7 postinfection with either PTg or PTgB parasites and uninfected
control mice. The cells were cultured for either 24 or 48 h with or
without Con A in the presence of rIL-2. Proliferation was determined
by the amount of [3H]thymidine incorporated, and the results ex-
pressed as counts per minute. Data present a representative experi-
ment with three mice per group. NM, normal mouse spleen cells; PTg,
PTg-infected spleen cells; PTgB, PTgB-infected spleen cells. This
experiment was repeated four times.
T-cell function can occur by a cell contact-dependent mecha-
nism, through a process of macrophage activation involving the
CD14 antigen (25).
The various soluble factors produced by macrophages that
may be implicated in downregulation of the immune response
include IL-10 (12, 14), TGF-P (42), nitric oxide (2, 30), and
TABLE 4. 125I-labeled IL-2 binding assay results for
high-affinity receptorsa
Spleen cell No. of binding Kd (PM)
type sites/cell
Uninfected 3,968 ± 2,258 A 45 ± 36 D
PTg infected 1,305 ± 1,077 B 40 ± 28 E
PTgB infected 1,498 ± 1,081 C 40 ± 27 E
a The results for binding of '25I-labeled IL-2 to its receptor on Con A-activated
uninfected and PTg- or PTgB-infected (for 7 days) splenocytes from two mice are
shown. The number of high-affinity binding sites and dissociation constant values
(Kd) were determined by Scatchard analysis. Comparisons were made using the
two-tailed student's t test: B versus A (P < 0.05), C versus A (P < 0.05), B versus
C (P > 0.05), E versus D (P > 0.05), and F versus D (P > 0.05).
TABLE 5. Production of IL-10 by splenocytes from T. gondii-
infected or uninfected mice after in vitro stimulation with Con A
Spleen cell type (U/ml)
PTg infected......................5.2 ± 1.0
Uninfected ...................... <1
PTg infected + macrophagesb ...................... 7.3 ± 2.0
Uninfected +c: pM0d
Infected macrophages...................... 3.5 ± 0.5
Uninfected macrophages...................... <1
a Spleen cells (2 X 105) from mice on day 7 postinfection with PTg parasites
or from uninfected mice were cultured in the presence of Con A. Supernatants
from 48-h cultures with Con A were assayed for IL-10 production by ELISA, and
the results are expressed as the means ± standard deviations of duplicates.
b Spleen cells from mice 7 days after infection cultured with macrophages
obtained from mice 7 days after infection.
c Uninfected +, uninfected mouse spleen cells cultured with macrophages
obtained either from mice 7 days after infection or from uninfected mice.
prostaglandin (32). Murine or human IL-10 has been shown to
exert an antagonistic effect on IL-2 production (14, 40). Our
results detected an increased level of IL-10 in the supernatant
of Con A-stimulated splenocytes from infected mice (Table 5).
The inhibitory activity of this supernatant can be partially
reversed by antibody to IL-10 (Table 6), suggesting that this
cytokine may be responsible in part for the reduced lympho-
proliferation as well as the alteration in production of IL-2 in
response to Con A.
Although TGF-, may mediate depression of immunity by
inhibiting cytokine production (9) during T cruzi infection
(36), it does not appear to play a role in downregulation of
immunity under the conditions in these experiments. However,
the inability to reverse the inhibitory effect of the infected
splenocytes by MAb to TGF-,B does not exclude its potential
importance under other experimental conditions during T.
gondii infection. Nitrogen intermediates, in particular, nitric
oxide, have also been shown to inhibit the proliferative re-
sponse of T cells (30). Recent studies suggest that nitric oxide
mediates, in part, the suppression observed in trypanosomiasis
(35). Earlier reports (1) have demonstrated the potential role
of this metabolite during infection with T. gondii. Using the
same number of Con A-stimulated splenocytes (2 x 105) that
exhibit downregulation of immunity, we were unable to detect
a significant increase in NO production over that by control. It
has been shown, however, that IL-10, whose production was
augmented with the same number of infected spleen cells, can
be a potent inhibitor of NO production (5, 6). With greater
numbers of cells (5 x 106), a significant increase in the amount
of NO produced by infected splenocytes (5.5 and 10 ,uM at 24
h and 48 h, respectively) compared with that by uninfected
spleen cells (2 and 5.3 ,uM at 24 and 48 h, respectively) was
demonstrated. Thus, we believe that NO does have a potential
role in downregulation of immunity; but in our system, at the
number of cells utilized, it is below the level of significance and
may not contribute to the observed effect. Studies with the NO
inhibitor, NMMA (NG-monomethyl-L-arginine), using more
effector cells (>2 x 106) than were utilized throughout these
experiments indicate that the inhibitory effect by the infected
splenocyte supernatant can be maximally reversed by approx-
imately 20 to 25% (22a).
Other than IL-10 induction, which appears to be partially
responsible for some of the immunosuppressive features we
have observed, other factors that may influence IL-2 produc-
tion could include (i) suppression of the IL-2 gene at the
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TABLE 6. Effects of anti-IL-l0 or anti-TGF-1 antibody on Con A-stimulated splenocytesu
IL-2 production (pM) with:
Spleen cell
type Medium only anti-bL-10 anti-TGF- Con A anti-IL-10 MAb anti-TGF-bC
MAnt-Lb MAnb-GF o+ Con A MAb + Con A
Uninfected 2,429 + 145 2,746 ± 251 3,670 1,349 87,566 + 9,296 99,781 + 9,062 86,909 ± 6,670
PTg infected 5,736 + 390 5,009 + 1,469 4,821 + 2,329 22,934 ± 246 73,823 + 4,030 22,261 ± 2,818
a The proliferative response of splenocytes to Con A in the presence of either rat anti-murine IL-10 or anti-TGF-1 MAb is shown. Spleen cells were obtained from
PTg-infected mice on day 7 postinfection and were cultured (2 x 105 cells per well) with Con A for 48 h in the presence of anti-IL-10 antibody (4 jig/ml) or anti-TGF-,
antibody (30 ,ug/ml). Rat immunoglobulin G was used as an isotype-matched control and did not shown any effects on the controls (2,533 ± 239 and 86,900 + 5,670,
respectively) or experimental group (5,810 ± 2,808 and 22,400 ± 245, respectively). The proliferation was measured by [3H]thymidine incorporation, and the results
are expressed as the means + standard deviations of triplicate wells. The experiment was repeated three times.
of IL-2 mRNA, (iii) the lack of IL-2-producing cells, and (iv)
production of other soluble, inhibitory factors. In summary,
our observations suggest that a state of transient immunode-
pression occurs during acute murine toxoplasmosis. This con-
dition appears to be mediated principally by macrophages
from infected mice. These macrophages are able to inhibit the
proliferative response of naive cells in response to Con A.
Further, these macrophages appear to affect the production of
IL-2, perhaps through the production of IL-10, which is at least
partially responsible for the observed effect.
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